Pankreasın Endokrin Hastalıkları
Özet
Pankreasın endokrin hastalıklarını ele alan bu metin, organın Langerhans Adacıkları üzerinden yürüttüğü hormonal fonksiyonları ve bu süreçteki bozuklukları detaylandırmaktadır. Pankreas nöroendokrin neoplazmları (PanNEN) ve Diabetes Mellitus (DM) olmak üzere iki ana kategoriye odaklanan çalışma, özellikle diyabetin küresel ve yerel artışına dikkat çekmektedir. Tip 1 diyabet mutlak insülin eksikliği ile karakterize edilirken, Tip 2 diyabet insülin direnci ve ilerleyici beta hücre kaybı ile tanımlanmaktadır. Metin ayrıca, monogenik defektler (MODY), ekzokrin pankreas hastalıkları (Tip 3c) ve endokrinopatiler gibi spesifik diyabet tiplerine de kapsamlı bir bakış sunmaktadır. Gestasyonel diyabetin maternal ve fetal riskleri vurgulanırken, hastalığın poliüri, polidipsi ve kilo kaybı gibi klasik klinik seyirleri açıklanmıştır. Diyabet tanısında açlık plazma glukozu, OGTT ve HbA1c kriterleri temel alınmakta, prediyabet aşamasındaki erken müdahalenin önemi belirtilmektedir. Sonuç olarak, pankreasın glukoz metabolizmasındaki hayati rolü ve diyabetin yarattığı ekonomik ve sağlık yükü karşısında obezitenin azaltılması ve erken teşhisin kritik olduğu savunulmaktadır.
This text, focusing on the endocrine diseases of the pancreas, details the organ's hormonal functions conducted through the Islets of Langerhans and the disorders arising in this process. Concentrating on two main categories, pancreatic neuroendocrine neoplasms (PanNEN) and Diabetes Mellitus (DM), the study highlights the global and local rise of diabetes. While Type 1 diabetes is characterized by absolute insulin deficiency, Type 2 diabetes is defined by insulin resistance and progressive beta-cell loss. The text also provides a comprehensive look at specific types of diabetes, such as monogenic defects (MODY), exocrine pancreatic diseases (Type 3c), and endocrinopathies. While the maternal and fetal risks of gestational diabetes are emphasized, the classical clinical courses of the disease, including polyuria, polydipsia, and weight loss, are explained. Fasting plasma glucose, OGTT, and HbA1c criteria are the basis for diabetes diagnosis, and the importance of early intervention during the prediabetes stage is noted. Consequently, it is argued that reducing obesity and achieving early diagnosis are critical in the face of the pancreas's vital role in glucose metabolism and the significant economic and health burden caused by diabetes.
Referanslar
Panzuto F, Nasoni S, Falconi M, et al. Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization. Endocr Relat Cancer. 2005;12(4):1083-1092. Doi:10.1677/erc.1.01017.
Inzani F, Petrone G, Rindi G. The New World Health Organization Classification for Pancreatic Neuroendocrine Neoplasia. Endocrinol Metab Clin North Am. 2018;47(3):463-470. Doi:10.1016/j.ecl.2018.04.008.
Ro C, Chai W, Yu VE, et al. Pancreatic neuroendocrine tumors: biology, diagnosis,and treatment. Chin J Cancer. 2013;32(6):312-324. Doi:10.5732/cjc.012.10295.
Alexakis N, Connor S, Ghaneh P, et al. Hereditary pancreatic endocrine tumours. Pancreatology. 2004;4(5):417-435. Doi:10.1159/000079616.
Heitz PU, Komminoth P, Perren A, et al. (2004). Pancreatic endocrine tumors: Introduction. Ronald A. DeLellis, Ricardo V. Lloyd, Philipp U. Heitz, Charles Eng (Ed.), Pancreatic endocrine tumours içinde (177-182). Lyon: IARC Press.
Metz DC, Jensen RT. Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors. Gastroenterology. 2008;135(5):1469-1492. Doi:10.1053/j.gastro.2008.05.047.
Klimstra DS. Nonductal neoplasms of the pancreas. Mod Pathol. 2007;20 Suppl 1:94-112. Doi:10.1038/modpathol.3800686.
Masharani U. (2021). Diabetes Mellitus and hypoglycemia. Maxine A. Papadakis, Stephen J. McPhee, Michael W. Rabow (Ed.), Current medical Diagnosis & Treatment.(Sixtieth edition) içinde (1242-1288). New York: McGraw-Hill.
World Health Organisation (WHO,2021). Diabetes. (19/12/2021 tarihinde https://www.who.int/news-room/fact-sheets/detail/diabetes adresinden ulaşılmıştır).
Wild S, Roglic G, Green A,et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047-1053. Doi:10.2337/diacare.27.5.1047.
International Diabetes Federation (2021). IDF Diabetes Atlas 2021-10th edition. (10/12/2021 tarihinde https://diabetesatlas.org/ adresinden erişilmiştir).
InterAct Consortium, Scott RA, Langenberg C, et al. The link between family history and risk of type 2 diabetes is not explained by anthropometric, lifestyle or genetic risk factors: the EPIC-InterAct study. Diabetologia. 2013;56(1):60-69. Doi:10.1007/s00125-012-2715-x.
BIRTH-GENE (BIG) Study Working Group, Huang T, Wang T, et al. Association of Birth Weight With Type 2 Diabetes and Glycemic Traits: A Mendelian Randomization Study. JAMA Netw Open. 2019;2(9):e1910915. Published 2019 Sep 4. Doi:10.1001/jamanetworkopen.2019.10915.
Nguyen NT, Nguyen XM, Lane J, et al. Relationship between obesity and diabetes in a US adult population: findings from the National Health and Nutrition Examination Survey, 1999-2006. Obes Surg. 2011;21(3):351-355. Doi:10.1007/s11695-010-0335-4.
Lao XQ, Deng HB, Liu X, et al. Increased leisure-time physical activity associated with lower onset of diabetes in 44 828 adults with impaired fasting glucose: a population-based prospective cohort study. Br J Sports Med. 2019;53(14):895-900. Doi:10.1136/bjsports-2017-098199.
Jameson JL. (2018). Endocrinology and Metabolism: Diabetes Mellitus. J. Larry Jameson, Anthony S. Fauci, Dennis L. Kasper, et al. Harrison's Principles of Internal Medicine, (20e Eds.) içinde (932-941). NewYork: McGraw-Hill. (10/12/2021 tarihinde https://accessmedicine.mhmedical.com/content.aspx?bookid=2129§ionid=159213747 adresinden ulaşılmıştır).
American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021 [published correction appears in Diabetes Care. 2021 Sep;44(9):2182]. Diabetes Care. 2021;44(Suppl-1):15-33. Doi:10.2337/dc21-S002.
Türkiye Endokrinoloji ve Metabolizma Derneği (TEMD,2020). Diabetes Mellitus ve Komplikasyonlarının Tanı, Tedavi ve İzlem Kılavuzu 2020. 14. Bs. (10/12/2021 tarihinde 20200625154506-2020tbl_kilavuz86bf012d90.pdf (temd.org.tr) adresinden ulaşılmıştır).
Chiang JL, Kirkman MS, Laffel LM, et al. Type 1 Diabetes Sourcebook Authors. Type 1 diabetes through the life span: a position statement of the American Diabetes Association. Diabetes Care. 2014;37(7):2034-2054. Doi:10.2337/dc14-1140.
Holt RIG, DeVries JH, Hess-Fischl A, et al. The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) [published correction appears in Diabetologia. 2022 Jan;65(1):255]. Diabetologia. 2021;64(12):2609-2652. Doi:10.1007/s00125-021-05568-3.
Türkiye Diyabet Vakfı (TÜRKDİAB). Diyabet Tanı ve Tedavi Rehberi. (2021). (15/12/2021 tarihinde https://www.turkdiab.org/admin/PICS/webfiles/Diyabet_Tani_ve_Tedavi_Rehberi_2021.pdf adresinden ulaşılmıştır).
Maruyama T, Nakagawa T, Kasuga A, et al. Heterogeneity among patients with latent autoimmune diabetes in adults. Diabetes Metab Res Rev. 2011;27(8):971-974. Doi:10.1002/dmrr.1238.
Liu L, Li X, Xiang Y, et al. Latent autoimmune diabetes in adults with low-titer GAD antibodies: similar disease progression with type 2 diabetes: a nationwide, multicenter prospective study (LADA China Study 3). Diabetes Care. 2015;38(1):16-21. Doi:10.2337/dc14-1770.
Robertson, RP (14 Aralık 2021). “Pathogenesis of type 2 diabetes mellitus.” In: UpToDate. (19/12/2021 tarihinde www.uptodate.com/contents/pathogenesis-of-type-2-diabetes-mellitus.adresinden ulaşılmıştır).
World Health Organization, Classification of diabetes mellitus (internet). World Health Organization; 2019. (19/12/2021 tarihinde https://apps.who.int/iris/handle/10665/325182 adresinden ulaşılmıştır).
Ledermann HM. Maturity-onset diabetes of the young (MODY) at least ten times more common in Europe than previously assumed? Diabetologia. 1995;38:1482.
Naylor R, Philipson LH. Who should have genetic testing for maturity-onset diabetes of the young?. Clin Endocrinol (Oxf). 2011;75(4):422-426. doi:10.1111/j.1365-2265.2011.04049.x.
Anık A, Çatlı G, Abacı A, et al. Maturity-onset diabetes of the young (MODY): an update. J Pediatr Endocrinol Metab. 2015;28(3-4):251-263. Doi:10.1515/jpem-2014-0384.
Ellard S, Bellanné-Chantelot C, Hattersley AT; European Molecular Genetics Quality Network (EMQN) MODY group. Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia. 2008;51(4):546-553. doi:10.1007/s00125-008-0942-y.
Thanabalasingham G, Owen KR. Diagnosis and management of maturity onset diabetes of the young (MODY). BMJ. 2011;343:d6044. Published 2011 Oct 19. Doi:10.1136/bmj.d6044.
Ewald N, Bretzel RG. Diabetes mellitus secondary to pancreatic diseases (Type 3c)--are we neglecting an important disease?. Eur J Intern Med. 2013;24(3):203-206. Doi:10.1016/j.ejim.2012.12.017.
Cui Y, Andersen DK. Pancreatogenic diabetes: special considerations for management. Pancreatology. 2011;11(3):279-294. Doi:10.1159/000329188.
Makuc J. Management of pancreatogenic diabetes: challenges and solutions. DiabetesMetabSyndrObes. 2016;9:311-315. Doi.org/10.2147/DMSO.S99701.
American Diabetes Association; 14. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes-2021. Diabetes Care. 2021;44(Suppl-1):200-210. Doi.org/10.2337/dc21-S014.
Hartling L, Dryden DM, Guthrie A, et al. Benefits and harms of treating gestational diabetes mellitus: a systematic review and meta-analysis for the U.S. Preventive Services Task Force and the National Institutes of Health Office of Medical Applications of Research. Ann Intern Med. 2013;159(2):123-129. Doi:10.7326/0003-4819-159-2-201307160-00661.
